About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Category Archives: Healthcare Communications and the Next Ten Years – A Series
Healthcare Communications and the Next Ten Years – Part 3 – PDUFA and Funding for the FDA
This is the third in a series that begins each week and on-going for a number of weeks, exploring specific topics related to changing health policies and their impact on healthcare communications. Let’s look at the money up close, shall … Continue reading
Posted in Healthcare Communications and the Next Ten Years - A Series
Comments Off on Healthcare Communications and the Next Ten Years – Part 3 – PDUFA and Funding for the FDA
Healthcare Communications and the Next Ten Years – Part 2 – DTC
This is the second in a series that begins each week and on-going for a number of weeks, exploring specific topics related to changing health policies and their impact on healthcare communications. One can instantly understand both the benefits and … Continue reading
Healthcare Communications and the Next Ten Years – Part 1 – RX to OTC Switches
Just as I offer Fridays as an opportunity to look back and digest what has happened during the week, I’ve decided to launch a new series, though abbreviated, that will be posted on Mondays. Entitled "Healthcare Communications and the Next … Continue reading
Posted in Healthcare Communications and the Next Ten Years - A Series
Comments Off on Healthcare Communications and the Next Ten Years – Part 1 – RX to OTC Switches